Details of the Drug

General Information of Drug (ID: DM8PU34)

• Drug Name: INB-100

Indication

Disease Entry	ICD 11	Status	REF
leukaemia	2A60-2B33	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DZ27CY

References

• [1] Clinical pipeline report, company report or official report of IN8bio.